Chronic fatigue syndrome with history of severe infection combined altered blood oxidant status, and reduced potassium efflux and muscle excitability at exercise by Jammes, Yves et al.
HAL Id: hal-01769413
https://hal-amu.archives-ouvertes.fr/hal-01769413
Submitted on 18 Apr 2018
HAL is a multi-disciplinary open access
archive for the deposit and dissemination of sci-
entific research documents, whether they are pub-
lished or not. The documents may come from
teaching and research institutions in France or
abroad, or from public or private research centers.
L’archive ouverte pluridisciplinaire HAL, est
destinée au dépôt et à la diffusion de documents
scientifiques de niveau recherche, publiés ou non,
émanant des établissements d’enseignement et de
recherche français ou étrangers, des laboratoires
publics ou privés.
Distributed under a Creative Commons Attribution| 4.0 International License
Chronic fatigue syndrome with history of severe
infection combined altered blood oxidant status, and
reduced potassium efflux and muscle excitability at
exercise
Yves Jammes, Jean Steinberg, Régis Guieu, Stephane Delliaux
To cite this version:
Yves Jammes, Jean Steinberg, Régis Guieu, Stephane Delliaux. Chronic fatigue syndrome with his-
tory of severe infection combined altered blood oxidant status, and reduced potassium efflux and
muscle excitability at exercise. Open journal of internal medicine, Scientific research, 2013, 3 (3),
￿10.4236/pjim.2013.33023￿. ￿hal-01769413￿
Open Journal of Internal Medicine, 2013, 3, 98-105                                                         OJIM 
http://dx.doi.org/10.4236/pjim.2013.33023 Published Online September 2013 (http://www.scirp.org/journal/ojim/) 
Chronic fatigue syndrome with history of severe infection 
combined altered blood oxidant status, and reduced  
potassium efflux and muscle excitability at exercise 
Yves Jammes1,2*, Jean Guillaume Steinberg2, Regis Guieu1, Stephane Delliaux1,2 
 
1UMR MD2, Faculty of Medicine, Aix-Marseille University, Marseille, France 
2Clinical Respiratory Physiology, Exercise Testing Laboratory, North Hospital, Public Health-Hospitals in Marseille, Marseille, France 
Email: *Yves.jammes@univ-amu.fr 
 
Received 30 January 2013; revised 28 February 2013; accepted 14 March 2013 
 
Copyright © 2013 Yves Jammes et al. This is an open access article distributed under the Creative Commons Attribution License, 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. 
ABSTRACT 
It is documented that chronic fatigue syndrome (CFS) 
combines enhanced oxidative stress with altered mus- 
cle excitability. We hypothesized that these disorders 
may be accentuated when severe infection preceded 
the CFS symptoms. This case-control study compared 
55 CFS patients to a matched control group of 40 
healthy subjects. In twenty-five CFS patients, severe 
infection was reported within the three to seven month 
period preceding the CFS symptoms. The others had 
practiced sport at high level. Plasma concentrations 
of potassium, a marker of lipid peroxidation (thio- 
barbituric acid reactive substances, TBARS), and an 
endogenous antioxidant (reduced ascorbic acid, RAA) 
were measured. Action potential (M-wave) was evoked 
in the vastus lateralis muscle to explore the muscle 
membrane excitability. All subjects performed a maxi- 
mal incremental cycling exercise. Compared to con- 
trol subjects, all CFS patients presented an elevated 
resting TBARS level and, during and after exercise, 
an altered M-wave configuration. History of infection 
was associated with marked significant increase in 
resting TBARS level, enhanced M-wave alterations, 
and also reduced exercise-induced potassium efflux. 
The magnitude of exercise-induced M-wave altera-
tions was proportional to the baseline TBARS level. 
Severe infection preceding CFS seems to constitute a 
stressor inducing altered blood oxidant status and a 
reduced muscle excitability at work. 
 
Keywords: Chronic Fatigue Syndrome; Infectious  
Diseases; Muscle Excitability; Oxidative Stress 
1. INTRODUCTION 
The Chronic Fatigue Syndrome (CFS) results in a severe 
impairment in sports and daily activities [1]. Exercise- 
induced CFS pathology is suspected [2,3]. However, 
CFS often follows severe bacterial or viral infection [4-6] 
and various suspected pathogens, like Epstein-Barr virus, 
cytomegalovirus, human herpes virus, enterovirus, par- 
vovirus and mycoplasma, have been considered. Previ- 
ous studies have reported marked alterations in biologi- 
cal and physiological responses to maximal exercise in 
CFS patients compared to healthy sedentary subjects 
[7-12]. These differences included marked post-exercise 
alterations of the muscle membrane excitability [7,8], an 
early and lengthened exercise-induced oxidative stress 
[7-13], and an attenuated heat shock proteins response 
(HSP) [8,13]. 
An excessive production of reactive oxygen species 
(ROS), responsible for membrane lipid peroxidation [14], 
exerts well known effects on isolated human and animal 
tissues, including the loss of membrane excitability due 
to an altered activation of potassium (K+) channels in 
cardiac myocytes [15] and skeletal muscle fibres [16]. In 
healthy humans, muscle biopsies have demonstrated that 
the strength of membrane excitation is proportional to 
the K+ efflux [17], detectable in plasma [18]. An in- 
creased ROS production exerts an inhibitory action on 
the Na+-K+ pump activity [14], reducing the potassium 
outflow and the muscle membrane excitability. The CFS 
study by Fulle et al. [19] has confirmed a deregulation of 
the Na+/K+ and Ca2+-ATPase pumps and the alterations 
of ryanodine channels in the sarcoplasmic reticulum mem- 
branes. These authors [19] have hypothesized that the 
deregulation of pump activities could result from an in- 
creased fluidity of the sarcoplasmic membrane due to the 
ROS-induced formation of lipid hydroperoxides. It is 
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well documented that severe bacterial [20] and viral [21- 
25] infections, including the H1N1 influenza [24,25], 
induce an oxidative stress. Thus, infection could be re- 
sponsible for an altered membrane excitability due to 
reduced K+ exchanges through the muscle membrane. 
Recording the compound evoked muscle action poten- 
tials (M-wave) with surface electrodes is a non-invasive 
tool, commonly used to explore the muscle membrane 
excitability in resting and exercising humans [7,26,27]. 
An impaired excitation of the muscle fibres is assessed 
when the M-wave declines and becomes broader. In 
healthy sedentary subjects, modest changes in M-wave 
duration and amplitude occur during and after a maximal 
incremental cycling exercise [7,26,27]. On the opposite, 
CFS patients present a significant lengthening of the 
neuromuscular conduction time (CT), a reduction of the 
M-wave amplitude, and lengthened M-wave duration, 
the altered muscle excitability often persisting at the end 
of a 30-min recovery period [7]. 
We hypothesized that the disorders of blood oxidant 
status and altered muscle membrane excitability could be 
accentuated in CFS patients with history of severe infec- 
tion. 
2. METHODS 
2.1. Subjects 
Fifty five CFS patients were explored. The criteria to 
include them were 1) clinical [1]: persistent or relapsing 
fatigue for at least 6 consecutive months or longer and 
four or more of the following symptoms: post-exertional 
malaise, impaired memory or concentration, unrefreshing 
sleep, muscle pain, multi-joint pain, tender cervical or 
axillary lymph nodes, sore throat, headache; and 2) bio- 
logical: the combination of exercise-induced alteration of 
the muscle membrane excitability [7,8] and an early and 
lengthened exercise-induced oxidative stress [7-13]. De- 
pression patients and chronic disease patients were ex- 
cluded in this study. Retrospectively, two groups of CFS 
patients were identified considering their history of sport 
practice and severe acute infection. Thirty of them had 
practiced sport at high level (>6 h per week) for more 
than six years before the symptoms had occurred and no 
history of severe infection was reported by their practi- 
tioners. In twenty five patients, who did not regularly 
practice any sport, severe infection (H1N1 influenza: 5; 
pneumonia: 7; encephalomyelitis: 6; sepsis: 4; unidenti- 
fied: 3) was reported within the three to seven month 
period preceding the onset of CFS symptoms. The two 
groups of CFS patients were called NI (not infected) and 
I (infected), respectively. The data were compared to 
those obtained in a gender, age-, and weight-matched 
control group of forty Caucasian healthy volunteers who 
consulted for a medical check up and were coming from 
the same type of socioeconomic class. Additional bio- 
chemical analyses in venous blood samples were approved 
by the Ethics Committee of our institution (CCPPRB 
Marseille 1) and the protocol was performed in accor- 
dance with the Declaration of Helsinki. The procedures 
were carried out with the adequate understanding and 
written consent of the subjects. The morphological char- 
acteristics of NI and I CFS patients and healthy subjects 
are collected in Table 1. 
2.2. Physiological Measurements 
The functional examinations at rest consisted in ECG 
recording, measurements of the arterial blood pressure 
 
Table 1. Comparison of controls and CFS patients. Morphological characteristics, maximal performances at work, baseline and 
maximal variations of venous plasma concentrations of lactic acid (LA), potassium (K+), and markers of oxidant/antioxidant status 
(TBARS, RAA) in healthy (control) subjects and CFS patients having history or not of recent severe infection (Infected or I CFS, 
non infected or NI CFS). 
 Controls NI CFS group I CFS group 
N 40 30 25 
F/M ratio 14/26 10/20 12/13 
Age, y 44 ± 5 39 ± 3 40 ± 3 
Weight, kg 71 ± 4 71 ± 2 66 ± 2 
VO2max, mlSTPD·min−1·kg−1 31 ± 3 29 ± 2 27 ± 1 
LA rest, mmol·l−1 1.30 ± 0.16 1.43 ± 0.11 1.40 ± 0.10 
Δ LAmax, % rest +382 ± 21 +381 ± 51 +328 ± 43 
K+ rest, mmol·l−1 4.02 ± 0.04 4.00 ± 0.05 3.93 ± 0.06 
Δ K+max, % rest +29 ± 3 +25 ± 2* +17 ± 4# 
TBARS rest, nmol·ml−1## 1.36 ± 0.07 1.87 ± 0.21#,*** 3.48 ± 0.40# 
Δ TBARSmax, % rest +57 ± 11 +149 ± 25#,** +66 ± 18 
RAA, rest nmol·ml−1 148 ± 10 134 ± 15 157 ± 19 
Δ RAAmax, % rest −51 ± 8 −30 ± 5 −33 ± 7 
Values are mean ± SE. Symbol #indicates significant difference between controls and CFS patients (#: p < 0.05) and asterisk depicts intergroup CFS differences 
(*: p < 0.05; **: p < 0.01; ***: p < 0.001). 
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measurements using a sphygmomanometer, the percuta- 
neous measurement of oxygen saturation (SpO2) using an 
infrared analyser (Nellcor model N3000, Tx, USA), and 
ventilation and respiratory gas exchange. A face mask 
was designed to form an air-tight seal over the patient’s 
nose and mouth, with all the inspired and expired gas 
going into a turbine flowmeter (Triple V digital volume 
transducer, Jaeger, Germany) giving measurements of min- 
ute ventilation. Fast-response paramagnetic O2 and in- 
frared CO2 analyzers measured the end-tidal partial pres- 
sures of O2 and CO2, respectively. Exercise trials were 
performed on an electrically braked cycle ergometer (Er- 
gometrics ER 800, Jaeger, Bunnik, The Netherlands) con- 
nected to a microcomputer software (Oxycon beta, Jae- 
ger, Bunnik, The Netherlands). The exercise bout was 
preceded by a 2-min 0-W pedalling period then the load 
was increased as a ramp (20 W/min) until the peak O2 
uptake (VO2max) was measured. The criteria to establish 
VO2max were to obtain a plateau of VO2, to reach pre- 
dicted maximal values of VO2 and HR, and to measure a 
respiratory quotient value higher than 1.1 [28]. 
2.3. Electromyographic (EMG) Recording and 
Analyses 
As in our previous studies [7,26,27], bipolar (30 mm 
center-to-center) Ag-AgCl surface electrodes (Dantec, 13 
L 20) were used to measure EMG voltage from the vas- 
tus lateralis muscle on the dominant side of the body. 
The electrodes were placed between the motor point and 
the proximal tendon. Inter-electrode impedance was kept 
below 2000 ohm by careful skin shaving and abrasion 
with an ether pad. The EMG signal was amplified (Ni- 
hon Kohden, Tokyo, Japan; common mode rejection 
ratio, 90 dB; input impedance, 100 mohm; gain, 1000 to 
5000) with a frequency band ranging from 10 to 2000 Hz. 
Compound muscle action potentials (M-waves) were 
evoked by direct muscle stimulation, using a monopolar 
technique. A constant-current neurostimulator (S88 model 
Grass, Quincy, MA, USA) delivered supramaximal shocks 
with 0.1-ms rectangular pulses through a Grass isolation 
unit. One small (1 × 1 cm) negative silver electrode was 
applied on the main motor point of the vastus lateralis 
muscle and a large (3 × 3 cm) positive silver electrode 
was placed on the opposite side of the thigh. The main 
motor point of this muscle was identified as the location 
of the cathode yielding the strongest contraction with the 
lowest pulse amplitude. To prevent any change in the 
electrode impedance throughout the whole challenge, the 
pulse intensity was set about 15 % above the level yield- 
ing an M wave of maximal amplitude during the 0-W 
pedalling period preceding the exercise bout. The EMG 
signal was fed to a numerical oscilloscope (model DSO 
400, Gould, Ballainvilliers, France), permitting to aver- 
age the M-waves from 8 successive potentials and to 
calculate 1) the peak M-wave amplitude; 2) its duration; 
and 3) the conduction time, that is the time between the 
stimulus artefact and the peak EMG response. To aver- 
age M waves elicited at constant muscle length, a trigger 
signal from a magnetic sensor coupled to the crank gear 
mechanism of the cycloergometer indicated the onset of 
the leg extension and thus of the vastus lateralis contrac- 
tion. It was used to trigger within a delay of 100 ms the 
neurostimulator delivering 0.1-ms-long rectangular pulses. 
Because the pedalling rate was set at 60 min−1, one leg 
extension was performed every sec and the stimulation 
frequency was set at 1 Hz. For each epoch of the proto- 
col (the 0-W cycling period preceding the incremental 
exercise, incremental exercise, and recovery period), 
eight successive evoked muscle potentials were averaged. 
Because M wave recordings must be performed during 
cycling at the same pedalling rate, the subject was asked 
to pedal again for several epochs during the recovery 
from exercise. 
2.4. Biochemical Analyses 
A catheter (Neofly 21 G, Viggo-Spectramed) was in- 
serted in an antecubital vein. Eight ml of heparinized 
blood were sampled at different sequences of the proto- 
col in order to measure biochemical variables. Lactic 
acid (LA) and potassium (K+) concentrations were meas- 
ured using specific electrodes (Corning-Chiron model 
860, Bayer Corporation, East Walpole, MA USA). A 
plasma marker of lipid peroxidation (thiobarbituric acid 
reactive substances, TBARS) and an antioxidant (re- 
duced ascorbic acid, RAA) were analyzed according to 
the original methods by Uchiyama and Mihara [29] for 
TBARS and Maickel [30] for RAA. All the measure- 
ments were made in duplicate. 
2.5. Exercise Protocol 
The protocol consisted of 1) a 30-min rest period, during 
which all the variables were measured and venous blood 
samples collected; 2) a 2-min 0-W work load period; 3) a 
work period, and 4) a 30-min recovery period. When 
VO2max was reached, venous blood was sampled and 
M-wave recorded. During the post-exercise recovery- 
period, venous blood samplings and M-wave recordings 
were performed at 5 and 30 min. 
2.6. Statistical Analyses 
Data are presented as means + standard error (SE). An 
independent Student’s t-test was performed to compare 
the baseline levels of biochemicals between the two groups 
of CFS patients and control subjects. For temporally re- 
peated data during rest, exercise, and recovery periods, 
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the changes over time were determined using ANOVA 
when the variables were normally distributed or a Fried- 
man’s test for repeated measures when they were not. 
When data were normally distributed, a two-way analy- 
sis of variance for repeated measures (RM-ANOVA 2) 
(i.e. groups and time) was used to determine the signifi- 
cance of changes throughout the cycling trial and the 
post-exercise recovery period. Post-hoc independent t- 
tests with Bonferroni corrections were used to compare 
time-point specific differences between groups. In all 
cases, significance was set at the two sides 0.05 level. 
3. RESULTS 
3.1. Examination at Rest 
No intergroup differences were noted between baseline 
values of LA, K+, and RAA concentrations whereas the 
mean value of resting TBARS level was significantly 
higher in CFS patients and almost doubled in the I CFS 
group (Table 1). The M-wave characteristics measured 
in the vastus lateralis at rest did not significantly differ 
between groups (Table 2). 
3.2. Response to Incremental Maximal Cycling 
VO2max and maximal LA concentration did not differ 
between the control and CFS groups (Table 1). Figure 1 
gives the kinetics of plasma TBARS, RAA, and K+ lev- 
els during and after exercise in the three groups. The 
TBARS level culminated at VO2max in all subjects. The 
maximal RAA decrease was measured at VO2max in 
CFS patients but later in healthy subjects, and the K+ 
concentration always culminated at VO2max. Table 1 
shows that compared to controls the maximal TBARS 
increase was almost doubled in NI CFS patients but did 
not significantly differ in the I CFS group. No intergroup 
differences were noted in the maximal RAA decrease. 
The peak K+ increase was significantly attenuated in the 
I CFS group. 
Marked M-wave changes occurred in CFS patients at 
VO2max and persisted after the exercise had ended. Fig- 
ure 2 gives examples of M-wave recordings in a control  
subject and a I CFS patient showing a marked depression 
in the latter. Figure 3 depicts the kinetics of the M-wave 
and CT changes in the three groups. The significance of 
intergroup differences was already present at VO2max 
and persisted at the 5th and 30th min. Table 2 shows that 
the largest exercise-induced M-wave variations occurred 
in the I CFS group. The M-wave alterations combined a 
decreased M-wave amplitude and a lengthened duration 
of both the M-wave and conduction time. 
Because our CFS patients were explored 6 to 23 months 
after the beginning of the muscle fatigue, we searched 
for relationships between this delay and the magnitude of 
resting values and exercise-induced variations of TBARS, 
RAA, K+ and M-wave characteristics in NI and I CFS 
groups. We found that the duration of the clinical disor- 
ders did not affect the biochemical and electrophysio- 
logical variables. 
3.3. Relationships between Biochemical and 
Electrophysiological Variables 
As shown in Figure 4, the post-exercise changes in M- 
wave amplitude and CT were proportional to the baseline 
TBARS level, the highest alterations being measured in 
the I CFS group. Despite their changes were near con- 
comitant, the maximal M-wave variations were not corre- 
lated to the maximal exercise-induced changes in TBARS, 
RAA, K+, and LA. 
4. DISCUSSION 
The present study confirms data previously reported in 
CFS patients, that is an elevation of the blood oxidant 
status at rest [7-13], an accentuated exercise-induced oxi- 
dative stress [7,8] and a reduced muscle excitability [7]. 
The new finding was the significant accentuation of the 
blood oxidant status disorders at rest and muscle hypo- 
excitability at work in CFS patients who reported a re- 
cent severe infection (I CFS group). It must be noted that 
the post-exercise oxidative stress (TBARS increase) was 
significantly enhanced in NI CFS group but not I CFS 
one. This might result from the marked elevation of the 
 
Table 2. M-wave characteristics (amplitude, duration) and neuromuscular conduction time (CT) measured during pre-exercise 0-W 
cycling period (reference, Ref) and their maximal exercise-induced variations in controls and the two groups of CFS patients. 
 Controls NI CFS group I CFS group 
M-wave amplitude Ref, mV 47 ± 9 43 ± 14 34 ± 16 
Δ M-wave amplitude max, % rest −16 ± 6 26 ± 6** −56 ± 10## 
M-wave duration Ref, ms 4.3 ± 0.7 4.2 ± 0.9 4.9 ± 1.0 
Δ M-wave duration max, % rest +8 ± 2 +25 ± 8#,** +45 ± 11## 
CT Ref, ms 0.73 ± 0.07 0.61 ± 0.14 0.83 ± 0.15 
Δ CTmax, % rest +5 ± 3 +15 ± 4#,* +30 ± 7## 
Values are mean ± SE. Symbol #indicates significant difference between controls and CFS patients (#: p < 0.05; ##: p < 0.01) and asterisk depicts intergroup CFS 
differences (*: p < 0.05; **: p < 0.01). 
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Figure 1. Plasma concentration of thiobarbituric acid reactive 
substances (TBARS) measured in control healthy subjects and 
both groups of CFS patients (non infected, or NI, and infected, 
or I) at rest, maximal oxygen uptake (VO2max), and during the 
post-exercise 30-min recovery period. Values are mean ± SEM. 
Symbol #denotes significant differences between controls and 
CFSs (##p < 0.01; ###p < 0.001). Asterisk was used to depict 
significant differences between NI and I CFS groups (*p < 0.05; 
**p < 0.01; ***p < 0.001). 
 
baseline TBARS concentration in I CFS patients which 
allows to suppose that the disorders of their oxidant status 
are already near maximal. The chronic elevation of the 
baseline TBARS level seems to play a key role in muscle 
excitability at work. Indeed, we measured the highest 
post-exercise alterations of muscle excitability in the I 
CFS group. We also noted a significant reduction of the 
muscle potassium outflow in response to maximal exer- 
cise in this group. 
The strength of this study was the relative accessibility 
of the tools used to diagnose CFS by most of the univer- 
 
Figure 2. Examples of M-wave recordings in vastus lateralis 
muscle in a control (healthy) subject and a CFS patient in the I 
group at rest, VO2max, and during the 30-min post-exercise 
recovery period. Stimulus (St) and M-wave are indicated. 
 
sity hospitals (M-wave recordings and plasma oxidant- 
antioxidant status). Its limitation was the absence of data 
on values of the heat shock proteins (HSP) in our CFS 
groups. Indeed, our previous studies [8,13] have clearly 
shown that both the baseline levels and exercise-induced 
variations of HSPs are significantly lower in these pa- 
tients. These measurements were not repeated in the pre- 
sent study because HSP measurements with immunoas- 
says kits are relatively expensive and can not be sup- 
ported by our grants. 
Our comparisons between control subjects and CFS 
patients at work are valuable because their VO2max and 
maximal exercise power, and thus the total duration of 
incremental exercise, did not significantly differ. The ab- 
sence of impaired aerobic metabolism in our CFS pa- 
tients corroborates several previous observations, based 
on the same [7] or nearly the same exercise protocol [31, 
32]. The accentuated exercise-induced oxidative stress in 
CFS patients might partly explain the absence of any 
impairment of their aerobic metabolism at work. Indeed, 
superoxide activates the mitochondrial uncoupling pro- 
teins [33] and the uncoupling processes are well known 
to enhance the oxygen uptake through their influence on 
the mitochondrial respiratory chain. 
The present study in CFS patients did not report any 
difference in resting values of the neuromuscular trans- 
mission (conduction time) and muscle membrane excit- 
ability compared to healthy subjects. On the other hand, 
we measured marked alterations of the muscle excitabil- 
ity at work which were already significant at the end of 
the incremental exercise and persisted during the recov- 
ery period. The reduction of the M-wave amplitude and 
the lengthening of the neuromuscular conduction time 
(CT) were significantly accentuated in CFS patients with  
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Figure 3. Absolute values of M-wave amplitude and duration, 
and the neuromuscular conduction time (CT) measured in 
control healthy subjects and CFS patients (non infected, or NI, 
and infected, or I) at rest, maximal oxygen uptake (VO2max) at 
the end of cycling exercise, and during the post-exercise 30-min 
recovery period. Values are mean ± SEM. Symbol #denotes 
significant differences between controls and CFS groups (#p < 
0.05; ##p < 0.01). Asterisk was used to depict significant 
differences between NI and I CFS groups (*p < 0.05; **p < 
0.01). 
 
history of recent severe infection. The enhanced altera- 
tions of post-exercise muscle membrane excitability in 
our I CFS group were associated with a significant re- 
duction of the maximal potassium outflow measured at 
the end of exercise. We already reported literature data 
[15-18] demonstrating close relationships between the 
oxidative stress, the K+ exchanges through the sarcolemma, 
and the muscle excitability. As demonstrated by Marcos 
and Ribas [18], an extracellular potassium accumulation 
can act as a negative feedback signal for sarcolemma 
excitability and might constitute a possible mechanism 
for the post-exercise M-wave alterations. 
 
Figure 4. Mean values (± SEM) of resting TBARS level and 
the corresponding maximal exercise-induced variations of the 
M-wave amplitude (upper panel) and neuromuscular conduction 
time (CT) (lower panel) in controls and CFS patients (non 
infected, or NI, and infected, or I). Tables 1 and 2 show the 
significance of intergroup differences. 
 
The present study indicates that CFS patients with an- 
tecedents of severe infection have higher biological and 
EMG disorders than other patients who solely reported 
practice of high physical activity before the occurrence 
of fatigue symptoms. It is well documented that acute 
infection constitutes a stress responsible for an oxidative 
stress [21-24]. Our major observation was that infection 
was responsible for lengthened alterations of the resting 
oxidant status. Indeed, the episode of infection occurred 
within the three to seven month period preceding the 
onset of CFS symptoms and our CFS patients were ex- 
plored 6 to 23 months after the beginning of fatigue. A 
persistent enhanced oxidant production is highly suspected 
to trigger the production of the tumor necrosis factor 
alpha, the most clearly defined mediator of contractile 
dysfunction. Some studies failed to demonstrate abnor- 
mal plasma cytokine levels in CFS patients at rest com- 
pared to healthy subjects [34,35] while others reported an 
elevation of plasma level of transforming growth fac- 
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tor-beta level, IL-6, and Il-1α [36,37]. 
In conclusion, we verified our hypothesis that severe 
infection represents a stressor responsible for a length- 
ened alteration of blood oxidant status which could ex- 
plain the impaired exercise-induced muscle potassium 
outflow and the altered membrane excitability in CFS 
patients. In these patients, free radical damage may be a 
contributor to the underlying functional defects during 
exercise and symptom presentation. 
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